COLL
Collegium Pharmaceutical Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$34.50
-0.50 ▼ -1.43%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$34.50
+0.00 +0.00%
| Index | RUT | P/E | 20.09 | EPS (ttm) | 1.72 | Insider Own | 3.91% | Shs Outstand | 0.03B | Perf Week | -7.48% |
| Market Cap | 1.10B | Forward P/E | 4.8 | EPS next Y | -12.02% | Insider Trans | -9.88% | Shs Float | 0.03B | Perf Month | -23.57% |
| Enterprise Value | 1.63B | PEG | - | EPS next Q | 1.81 | Inst Own | 118.75% | Short Float | 15.07% | Perf Quarter | -29.39% |
| Income | 0.06B | P/S | 1.4 | EPS this Y | 10.04% | Inst Trans | 0.04% | Short Ratio | 9.88 | Perf Half Y | -11.67% |
| Sales | 0.78B | P/B | 3.63 | EPS next 5Y | -3.25% | ROA | 3.75% | Short Interest | 4.60M | Perf YTD | -25.49% |
| Book/sh | 9.51 | P/C | 2.69 | EPS past 3/5Y | - 17.92% | ROE | 23.7% | 52W High | -32.07% ($50.79) | Perf Year | 18.56% |
| Cash/sh | 12.8 | P/FCF | 3.34 | Sales past 3/5Y | 18.94% 20.28% | ROIC | 5.21% | 52W Low | 48.51% ($23.23) | Perf 3Y | 44.05% |
| Dividend Est. | - | EV/EBITDA | 3.96 | EPS Y/Y TTM | -7.25% | Gross Margin | 59.35% | Volatility(W/M) | 3.15% 3.6% | Perf 5Y | 35.61% |
| Dividend TTM | - | EV/Sales | 2.08 | Sales Y/Y TTM | 23.62% | Oper. Margin | 23.58% | ATR (14) | 1.55 | Perf 10Y | 95.36% |
| Dividend Ex-Date | - | Quick Ratio | 1.48 | EPS Q/Q | 31.51% | Profit Margin | 8.05% | RSI (14) | 16.58 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.57 | Sales Q/Q | 12.92% | SMA20 | -16.24% ($41.19) | Beta | 0.73 | Target Price | $53.83 |
| Payout | - | Debt/Eq | 3.1 | Earnings | 2000000 | SMA50 | -22.26% ($44.38) | Rel Volume | 0.89 | Prev Close | $35 |
| Employees | 423 | LT Debt/Eq | 3 | EPS/Sales Surpr. | -4.64% -0.44% | SMA200 | -11.05% ($38.79) | Avg Volume(3M) | 0.47M | Price | $34.5 |
| IPO | 2015/5/7 | Option/Short | Yes/Yes | Trades | 5885 | Volume | 413,490 | Change | -1.43% |
뉴스 로딩 중...